Chongqing Porton Pharmaceutical Technology (SHE: 300363)

Chongqing Porton Pharmaceutical Technology is a corporation based in. Established in 2005, the company provides end-to-end CDMO and CRO services for small molecules, peptides, oligonucleotides, biologics, conjugates (ADCs, AOCs, PDCs), and advanced therapy medicinal products. Its offerings span cell banking, process and analytical development, GMP manufacturing, testing, and fill-finish across preclinical to commercial stages. The assets are managed by the executive management team.